CUNY-Graduate School of Public Health: National Study Finds Low Uptake of COVID-19 Oral Antivirals
February 22, 2024
February 22, 2024
NEW YORK, Feb. 22 (TNSres) -- The City University of New York's Graduate School of Public Health and Health Policy issued the following news release:
A study conducted by CUNY SPH investigators in the Institute for Implementation Science in Population Health examined the uptake of oral COVID-19 antivirals, specifically nirmatrelvir/ritonavir (NMV/r, also known as Paxlovid), and molnupiravir (MOV), among a highly vaccinated adult cohort (n=1,622) in the United States who were infecte . . .
A study conducted by CUNY SPH investigators in the Institute for Implementation Science in Population Health examined the uptake of oral COVID-19 antivirals, specifically nirmatrelvir/ritonavir (NMV/r, also known as Paxlovid), and molnupiravir (MOV), among a highly vaccinated adult cohort (n=1,622) in the United States who were infecte . . .